-
EP3831811
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3831811
| EP3831811 - HETEROCYCLIC COMPOUND [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 07.05.2021 Database last updated on 19.10.2024 | |
| Former | The international publication has been made Status updated on 08.02.2020 | Most recent event Tooltip | 26.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Fimecs, Inc. 26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa, 251-0012 / JP | [2021/23] | Inventor(s) | 01 /
TOMINARI, Yusuke c/o FIMECS, Inc.,26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012 / JP | 02 /
TOMATA, Yoshihide c/o FIMECS, Inc.,26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012 / JP | 03 /
GAMO, Kanae c/o FIMECS, Inc.,26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012 / JP | 04 /
KITAMOTO, Naomi c/o FIMECS, Inc.,26-1, Muraoka-Higashi 2-chome Fujisawa-shi, Kanagawa 251-0012 / JP | [2021/23] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2021/23] | Application number, filing date | 19843599.2 | 31.07.2019 | [2021/23] | WO2019JP30083 | Priority number, date | JP20180144308 | 31.07.2018 Original published format: JP 2018144308 | [2021/23] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020027225 | Date: | 06.02.2020 | Language: | JA | [2020/06] | Type: | A1 Application with search report | No.: | EP3831811 | Date: | 09.06.2021 | Language: | EN | [2021/23] | Search report(s) | International search report - published on: | JP | 06.02.2020 | (Supplementary) European search report - dispatched on: | EP | 21.03.2022 | Classification | IPC: | C07D209/42, C07D231/14, C07D231/56, C07D235/08, C07D403/06, C07D403/12, C07D413/14, C07D471/04, C07D487/04, A61K31/496, A61K31/519, A61K31/5377, A61P35/00, A61P35/02, A61P35/04, A61P43/00 | [2022/16] | CPC: |
C07D417/14 (EP,US);
C07D471/04 (US);
A61P35/00 (EP);
A61P35/02 (EP);
A61P35/04 (EP);
A61P43/00 (EP);
C07D209/08 (EP,US);
C07D209/30 (EP);
C07D209/42 (EP,US);
C07D231/14 (US);
C07D231/56 (US);
C07D235/08 (US);
C07D403/06 (US);
C07D403/12 (US);
C07D403/14 (EP);
C07D413/14 (US);
C07D487/04 (US);
C07D487/08 (US);
|
| Former IPC [2021/23] | C07D209/42, A61K31/496, A61K31/519, A61K31/5377, A61P35/00, A61P35/02, A61P35/04, A61P43/00, C07D231/14, C07D231/56, C07D235/08, C07D403/06, C07D403/12, C07D413/14, C07D471/04, C07D487/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/23] | Title | German: | HETEROCYCLISCHE VERBINDUNG | [2021/23] | English: | HETEROCYCLIC COMPOUND | [2021/23] | French: | COMPOSÉ HÉTÉROCYCLIQUE | [2021/23] | Entry into regional phase | 25.01.2021 | Translation filed | 25.01.2021 | National basic fee paid | 25.01.2021 | Search fee paid | 25.01.2021 | Designation fee(s) paid | 25.01.2021 | Examination fee paid | Examination procedure | 25.01.2021 | Examination requested [2021/23] | 07.10.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 26.07.2021 | Renewal fee patent year 03 | 27.07.2022 | Renewal fee patent year 04 | 26.07.2023 | Renewal fee patent year 05 | 25.07.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [YD]WO2011098904 (AEGERA THERAPEUTICS INC [CA], et al); | [XY]WO2012080271 (NOVARTIS AG [CH], et al); | [XY]WO2014031487 (REGENTIS OF THE UNIVERSITY OF MICHIGAN [US]); | [Y]WO2017194390 (HOFFMANN LA ROCHE [CH], et al); | International search | [A]JP2008536861 ; | [A]WO2009155709 (AEGERA THERAPEUTICS INC [CA], et al); | [A]JP2012176934 (TAKEDA CHEMICAL INDUSTRIES LTD); | by applicant | US2002068063 | US2004038358 | WO2006075023 | WO2006091737 | WO2006113376 | US2007093428 | WO2007104162 | WO2007106192 | WO2007131366 | WO2008016893 | WO2008045905 | WO2008079735 | WO2008128171 | US2009156508 | US2010075910 | WO2010142994 | WO2011002684 | WO2011005761 | WO2011098904 | US2011212882 | WO2011143657 | JP2012106958 | JP2012176934 | WO2012143726 | JP2013056837 | US2013172264 | WO2013106643 | WO2013106646 | WO2014023708 | WO2014060770 | US2014135270 | WO2014108452 | WO2014180524 | WO2015000867 | WO2015000868 | US2015291562 | WO2015160845 | US2016045607 | WO2016105518 | WO2016118666 | WO2016146985 | WO2016172134 | WO2016169989 | WO2016197114 | WO2016197032 | US2017008904 | WO2017007612 | WO2017011371 | WO2017011590 | WO2017024318 | WO2017030814 | US2017065719 | US2017121321 | CN106749513 | WO2017117473 | WO2017117474 | CN106977584 | WO2017181061 | WO2017185036 | WO2017182418 | WO2017197056 | WO2017197055 | WO2017197051 | WO2017197046 | WO2017197036 | WO2017201449 | CN107382862 | WO2017204445 | WO2017211924 | CN107540608 | US2018072711 | WO2018053354 | WO2018051107 | US2018099940 | WO2018066545 | US2018118733 | US2018134684 | US2018134688 | WO2018102725 | WO2018102067 | US2018155322 | US2018169109 | WO2018119448 | WO2018119357 | WO2018119441 | US2018179522 | US2018179183 | US2018186785 | US2018193470 | US2018215731 | WO2018140809 | WO2018144649 | US2018228907 | WO2018148443 | US2018237418 | US2018256586 | WO2018189554 | US2018327419 | WO2018237026 | WO2019014429 | US2019062281 | WO2019060742 | WO2019079701 | WO2019079357 | WO2019078522 | US2019119358 | US2019119271 | WO2019084030 | WO2019084026 | US2019127359 | WO2019094772 | WO2019094718 | WO2019099926 | US2019151457 | WO2019113071 | WO2019109415 | US2019175612 | WO2019114770 | WO2019118893 | WO2019123367 | US2019192514 | WO2019133531 | WO2019140003 |